226 related articles for article (PubMed ID: 28677022)
1. Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer.
Wong M; Oo TH; Qiao W; Garg N; Rojas-Hernandez CM
J Thromb Thrombolysis; 2017 Aug; 44(2):261-266. PubMed ID: 28677022
[TBL] [Abstract][Full Text] [Related]
2. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
Raschke RA; Curry SC; Warkentin TE; Gerkin RD
Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
[TBL] [Abstract][Full Text] [Related]
3. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
4. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
7. Utility of ELISA optical density values and clinical scores for the diagnosis of and thrombosis prediction in heparin-induced thrombocytopenia.
Kim SY; Kim HK; Han KS; Kim I; Yoon SS; Park S; Kim BK
Korean J Lab Med; 2011 Jan; 31(1):1-8. PubMed ID: 21239863
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
[TBL] [Abstract][Full Text] [Related]
9. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.
Whitlatch NL; Perry SL; Ortel TL
Thromb Haemost; 2008 Oct; 100(4):678-84. PubMed ID: 18841292
[TBL] [Abstract][Full Text] [Related]
10. Correlation of ELISA optical density with clinical diagnosis of heparin-induced thrombocytopenia: a retrospective study of 104 patients with positive anti-PF4/heparin ELISA.
Pearson MA; Nadeau C; Blais N
Clin Appl Thromb Hemost; 2014 May; 20(4):349-54. PubMed ID: 24288385
[TBL] [Abstract][Full Text] [Related]
11. Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.
Nellen V; Sulzer I; Barizzi G; Lämmle B; Alberio L
Haematologica; 2012 Jan; 97(1):89-97. PubMed ID: 21933856
[TBL] [Abstract][Full Text] [Related]
12. Limited impact of clinician education on reducing inappropriate PF4 testing for heparin-induced thrombocytopenia.
Malalur P; Greenberg C; Lim MY
J Thromb Thrombolysis; 2019 Feb; 47(2):287-291. PubMed ID: 30612329
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of automatized PF4/heparin immunoassays HemosIL HIT-ab (PF4-H) for the diagnosis of heparin-induced thrombocytopenia.
Jourdy Y; Nougier C; Rugeri L; Bordet JC; Sobas F; Negrier C
Int J Lab Hematol; 2015 Apr; 37(2):244-52. PubMed ID: 25041633
[TBL] [Abstract][Full Text] [Related]
14. Serotonin-release assay-negative heparin-induced thrombocytopenia.
Warkentin TE; Nazy I; Sheppard JI; Smith JW; Kelton JG; Arnold DM
Am J Hematol; 2020 Jan; 95(1):38-47. PubMed ID: 31621093
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of heparin induced thrombocytopenia using probability scores in a mechanical circulatory support population.
Thomas T; Fuentes A; Xu Q; Donahue K
J Thromb Thrombolysis; 2019 Jul; 48(1):134-140. PubMed ID: 30919254
[TBL] [Abstract][Full Text] [Related]
16. Comparison of an IgG-Specific Enzyme-Linked Immunosorbent Assay Cutoff of 0.4 Versus 0.8 and 1.0 Optical Density Units for Heparin-Induced Thrombocytopenia.
Ritchie BM; Connors JM; Sylvester KW
Clin Appl Thromb Hemost; 2017 Apr; 23(3):282-286. PubMed ID: 26400659
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
[TBL] [Abstract][Full Text] [Related]
18. Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.
McFarland J; Lochowicz A; Aster R; Chappell B; Curtis B
Am J Hematol; 2012 Aug; 87(8):776-81. PubMed ID: 22641378
[TBL] [Abstract][Full Text] [Related]
19. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia.
Arepally G; Reynolds C; Tomaski A; Amiral J; Jawad A; Poncz M; Cines DB
Am J Clin Pathol; 1995 Dec; 104(6):648-54. PubMed ID: 8526207
[TBL] [Abstract][Full Text] [Related]
20. External validation of the HIT Expert Probability (HEP) score.
Joseph L; Gomes MP; Al Solaiman F; St John J; Ozaki A; Raju M; Dhariwal M; Kim ES
Thromb Haemost; 2015 Mar; 113(3):633-40. PubMed ID: 25588983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
